1742 related articles for article (PubMed ID: 23956253)
1. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
2. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
[TBL] [Abstract][Full Text] [Related]
3. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.
Cuchel M; Bruckert E; Ginsberg HN; Raal FJ; Santos RD; Hegele RA; Kuivenhoven JA; Nordestgaard BG; Descamps OS; Steinhagen-Thiessen E; Tybjærg-Hansen A; Watts GF; Averna M; Boileau C; Borén J; Catapano AL; Defesche JC; Hovingh GK; Humphries SE; Kovanen PT; Masana L; Pajukanta P; Parhofer KG; Ray KK; Stalenhoef AF; Stroes E; Taskinen MR; Wiegman A; Wiklund O; Chapman MJ;
Eur Heart J; 2014 Aug; 35(32):2146-57. PubMed ID: 25053660
[TBL] [Abstract][Full Text] [Related]
4. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
5. [A YOUNG MAN WHOSE LDL-CHOLESTEROL IS GREATER THAN 1.9 G/L].
Cariou B
Rev Prat; 2015 Oct; 65(8):1062-6. PubMed ID: 26749708
[TBL] [Abstract][Full Text] [Related]
6. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
7. Familial hypercholesterolemia--improving treatment and meeting guidelines.
Hopkins PN
Int J Cardiol; 2003 May; 89(1):13-23. PubMed ID: 12727001
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries.
Ramaswami U; Futema M; Bogsrud MP; Holven KB; Roeters van Lennep J; Wiegman A; Descamps OS; Vrablik M; Freiberger T; Dieplinger H; Greber-Platzer S; Hanauer-Mader G; Bourbon M; Drogari E; Humphries SE
Atherosclerosis; 2020 Jan; 292():178-187. PubMed ID: 31809987
[TBL] [Abstract][Full Text] [Related]
9. Familial hypercholesterolemia treatments: Guidelines and new therapies.
Raal FJ; Hovingh GK; Catapano AL
Atherosclerosis; 2018 Oct; 277():483-492. PubMed ID: 30270089
[TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners.
Anagnostis P; Antza C; Florentin M; Kotsis V
Kardiol Pol; 2023; 81(11):1081-1088. PubMed ID: 37937357
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
[TBL] [Abstract][Full Text] [Related]
13. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
[TBL] [Abstract][Full Text] [Related]
14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
15. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).
Schaefer JR; Kurt B; Sattler A; Klaus G; Soufi M
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):2-6. PubMed ID: 22528129
[TBL] [Abstract][Full Text] [Related]
17. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH
Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069
[TBL] [Abstract][Full Text] [Related]
18. Familial hypercholesterolaemia: a model of care for Australasia.
Watts GF; Sullivan DR; Poplawski N; van Bockxmeer F; Hamilton-Craig I; Clifton PM; O'Brien R; Bishop W; George P; Barter PJ; Bates T; Burnett JR; Coakley J; Davidson P; Emery J; Martin A; Farid W; Freeman L; Geelhoed E; Juniper A; Kidd A; Kostner K; Krass I; Livingston M; Maxwell S; O'Leary P; Owaimrin A; Redgrave TG; Reid N; Southwell L; Suthers G; Tonkin A; Towler S; Trent R;
Atheroscler Suppl; 2011 Oct; 12(2):221-63. PubMed ID: 21917530
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the management of familial hypercholesterolemia.
Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
[TBL] [Abstract][Full Text] [Related]
20. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
